Remove 2004 Remove Epilepsy Remove History Remove Patients
article thumbnail

Is weed legal in Greece?

The Cannigma

Greek drug laws have gone through a series of amendments since the passing of law nº 1729/87 in 1987, which had at its core a view of drug addicts as patients as opposed to criminals. The history of cannabis in Greece can be traced back to the ancient Greeks and Romans, who used hemp fiber for boat sails, ropes, clothes, and much more.

article thumbnail

Election Brings Big Wins for Cannabis Legalization

Canna Care Docs

Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients. Medicinal cannabis was already approved in Montana in 2004. The passing initiative legalizes cannabis prescriptions for 22 medical conditions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is weed legal in the UK?

The Cannigma

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It also has an extensive and diverse history of medicinal use. Refractory paediatric epilepsy. Conclusions.